Answers are grounded in this paper and cite their sources.
Background: Iron deficiency anaemia (IDA) is a prevalent global health problem associated with significant morbidity. Traditional oral iron therapy is often limited by gastrointestinal side effects and poor absorption. Intravenous (IV) iron may provide a faster and more effective alternative.Objective: This study aims to compare the efficacy and safety of IV iron replacement with oral iron supplementation in patients with IDA.Methods: A randomized, single-centre, prospective interventional study was conducted with 200 adult patients diagnosed with IDA. Patients were randomized into two groups: IV iron (ferric carboxymaltose) or oral iron (ferrous sulphate) for 12 weeks. Haemoglobin and ferritin levels were measured at baseline, 6 weeks, and 12 weeks. Treatment adherence and adverse effects were also monitored.Results: The IV iron group showed a significantly higher mean increase in haemoglobin (4.3 ± 1.1 g/dL) compared to the oral iron group (2.7 ± 1.4 g/dL, p < 0.001). Ferritin levels improved by 69.6 ± 14.2 ng/mL in the IV group versus 29.5 ± 10.8 ng/mL in the oral group (p < 0.001).Conclusion: IV iron is more effective and better tolerated than oral iron for IDA management, particularly in scenarios requiring rapid correction.
No takes yet. Share an insight, caveat, or question.
Younis et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: